opc 21268 has been researched along with Hypercholesterolemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, K; Hirai, M; Imai, Y; Kurihara, I; Obara, K; Saito, T; Sato, H; Shoji, Y; Soma, J | 1 |
1 other study(ies) available for opc 21268 and Hypercholesterolemia
| Article | Year |
|---|---|
Effect of a nonpeptide vasopressin V1 antagonist (OPC-21268) on experimental accelerated focal glomerulosclerosis.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Blood Pressure; Blood Urea Nitrogen; Glomerulosclerosis, Focal Segmental; Hypercholesterolemia; Kidney; Kidney Function Tests; Lipids; Male; Nephrectomy; Piperidines; Proteinuria; Quinolones; Rats; Rats, Inbred Strains | 1996 |